Tuesday, 27 December 2011

Azulemin




Azulemin may be available in the countries listed below.


Ingredient matches for Azulemin



Glutamine

Glutamine is reported as an ingredient of Azulemin in the following countries:


  • Japan

Sodium Gualenate

Sodium Gualenate is reported as an ingredient of Azulemin in the following countries:


  • Japan

International Drug Name Search

Saturday, 17 December 2011

Along




Along may be available in the countries listed below.


Ingredient matches for Along



Betaxolol

Betaxolol hydrochloride (a derivative of Betaxolol) is reported as an ingredient of Along in the following countries:


  • Japan

International Drug Name Search

Friday, 9 December 2011

Diclotab




Diclotab may be available in the countries listed below.


Ingredient matches for Diclotab



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclotab in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, 8 December 2011

Vetin




Vetin may be available in the countries listed below.


Ingredient matches for Vetin



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Vetin in the following countries:


  • Taiwan

International Drug Name Search

Gaboton




Gaboton may be available in the countries listed below.


Ingredient matches for Gaboton



Gabapentin

Gabapentin is reported as an ingredient of Gaboton in the following countries:


  • Bangladesh

  • Romania

  • Slovenia

International Drug Name Search

Monday, 28 November 2011

Vicks Vaposyrup Expectorant




Vicks Vaposyrup Expectorant may be available in the countries listed below.


Ingredient matches for Vicks Vaposyrup Expectorant



Guaifenesin

Guaifenesin is reported as an ingredient of Vicks Vaposyrup Expectorant in the following countries:


  • Belgium

International Drug Name Search

Sunday, 27 November 2011

Zeldox




Zeldox may be available in the countries listed below.


Ingredient matches for Zeldox



Ziprasidone

Ziprasidone is reported as an ingredient of Zeldox in the following countries:


  • Argentina

  • Slovakia

  • Tunisia

Ziprasidone hydrochloride monohydrate (a derivative of Ziprasidone) is reported as an ingredient of Zeldox in the following countries:


  • Australia

  • Austria

  • Bosnia & Herzegowina

  • Canada

  • Chile

  • China

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • Georgia

  • Germany

  • Hong Kong

  • Iceland

  • Latvia

  • Lithuania

  • Luxembourg

  • Malaysia

  • New Zealand

  • Norway

  • Oman

  • Peru

  • Philippines

  • Poland

  • Portugal

  • Romania

  • Russian Federation

  • Serbia

  • Singapore

  • Slovenia

  • Spain

  • Sweden

  • Thailand

  • Turkey

Ziprasidone mesylate (a derivative of Ziprasidone) is reported as an ingredient of Zeldox in the following countries:


  • Austria

  • Chile

  • Czech Republic

  • Estonia

  • Finland

  • Germany

  • Hong Kong

  • Hungary

  • Iceland

  • Malaysia

  • Peru

  • Philippines

  • Portugal

  • Spain

  • Sweden

  • Thailand

International Drug Name Search

Wednesday, 23 November 2011

Dopamina Ahimsa




Dopamina Ahimsa may be available in the countries listed below.


Ingredient matches for Dopamina Ahimsa



Dopamine

Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of Dopamina Ahimsa in the following countries:


  • Argentina

International Drug Name Search

Sunday, 20 November 2011

Cizap




Cizap may be available in the countries listed below.


Ingredient matches for Cizap



Cisapride

Cisapride is reported as an ingredient of Cizap in the following countries:


  • India

International Drug Name Search

Saturday, 19 November 2011

Bensau




Bensau may be available in the countries listed below.


Ingredient matches for Bensau



Benzonatate

Benzonatate is reported as an ingredient of Bensau in the following countries:


  • Taiwan

International Drug Name Search

Acido Alendronico Semanal Qualigen




Acido Alendronico Semanal Qualigen may be available in the countries listed below.


Ingredient matches for Acido Alendronico Semanal Qualigen



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Acido Alendronico Semanal Qualigen in the following countries:


  • Spain

International Drug Name Search

Tuesday, 15 November 2011

X Spore




X Spore may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for X Spore



Carbendazim

Carbendazim is reported as an ingredient of X Spore in the following countries:


  • New Zealand

International Drug Name Search

Monday, 14 November 2011

Paracetamol Agrand




Paracetamol Agrand may be available in the countries listed below.


Ingredient matches for Paracetamol Agrand



Paracetamol

Paracetamol is reported as an ingredient of Paracetamol Agrand in the following countries:


  • Argentina

International Drug Name Search

Saturday, 12 November 2011

Calsil




Calsil may be available in the countries listed below.


Ingredient matches for Calsil



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Calsil in the following countries:


  • Bangladesh

Paracetamol

Paracetamol is reported as an ingredient of Calsil in the following countries:


  • Japan

International Drug Name Search

Wednesday, 9 November 2011

Ascard




Ascard may be available in the countries listed below.


Ingredient matches for Ascard



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Ascard in the following countries:


  • Ethiopia

International Drug Name Search

Sunday, 6 November 2011

Codifarma




Codifarma may be available in the countries listed below.


Ingredient matches for Codifarma



Codeine

Codeine is reported as an ingredient of Codifarma in the following countries:


  • Peru

International Drug Name Search

Thursday, 27 October 2011

Anxibloc




Anxibloc may be available in the countries listed below.


Ingredient matches for Anxibloc



Clobazam

Clobazam is reported as an ingredient of Anxibloc in the following countries:


  • Indonesia

International Drug Name Search

AT III




AT III may be available in the countries listed below.


Ingredient matches for AT III



Antithrombin Iii

Antithrombin III is reported as an ingredient of AT III in the following countries:


  • Brazil

  • Germany

  • Italy

International Drug Name Search

Tuesday, 25 October 2011

Atenolol Solka




Atenolol Solka may be available in the countries listed below.


Ingredient matches for Atenolol Solka



Atenolol

Atenolol is reported as an ingredient of Atenolol Solka in the following countries:


  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Honduras

  • Nicaragua

International Drug Name Search

Atrovent HFA


Atrovent HFA is a brand name of ipratropium, approved by the FDA in the following formulation(s):


ATROVENT HFA (ipratropium bromide - aerosol, metered; inhalation)



  • Manufacturer: BOEHRINGER INGELHEIM

    Approval date: November 27, 2004

    Strength(s): 0.021MG/INH [RLD]

Has a generic version of Atrovent HFA been approved?


No. There is currently no therapeutically equivalent version of Atrovent HFA available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Atrovent HFA. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Stabilized medicinal aerosol solution formulations
    Patent 5,676,930
    Issued: October 14, 1997
    Inventor(s): Jager; Paul Donald & Kontny; Mark James & Nagel; Jurgen Hubert
    Assignee(s): Boehringer Ingelheim Pharmaceuticals, Inc.
    Stabilized medicinal aerosol solution formulations comprising medicaments that degrade or decompose by interaction with solvents or water, an HFC propellant, a cosolvent and an acid are described. Further, specific medicinal aerosol solution formulations comprising ipratropium bromide or fenoterol, ethyl alcohol, 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoropropane, and either an inorganic acid or an organic acid are described. The acids are present in amounts sufficient to reduce the degradation of the medicaments to acceptable levels.
    Patent expiration dates:

    • October 14, 2014
      ✓ 
      Drug product




  • Medicinal aerosol formulations
    Patent 5,683,677
    Issued: November 4, 1997
    Inventor(s): Purewal; Tarlochan S. & Greenleaf; David J.
    Assignee(s): Riker Laboratories, Inc.
    A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.
    Patent expiration dates:

    • November 4, 2014
      ✓ 
      Drug product




  • Stainless steel canister for propellant-driven metering aerosols
    Patent 6,739,333
    Issued: May 25, 2004
    Inventor(s): Hubert; Hoelz & Richard Thomas; Lostritto & Juergen; Nagel & Julio César; Vega
    Assignee(s): Boehringer Ingelheim Pharma KG
    The present invention relates to corrosion resistant stainless steel canisters for propellant-containing aerosol forumlations for use in propellant gas-operated inhalers.
    Patent expiration dates:

    • May 26, 2020
      ✓ 
      Drug product




  • Stainless steel canister for propellant-driven metering aerosols
    Patent 6,983,743
    Issued: January 10, 2006
    Inventor(s): Hoelz; Hubert & Lostritto; Richard Thomas & Nagel; Juergen & Vega; Julio César
    Assignee(s): Boehringer Ingelheim Pharma KG
    The present invention relates to corrosion resistant stainless steel canisters for propellant-containing aerosol formulations for use in propellant gas-operated inhalers.
    Patent expiration dates:

    • May 26, 2020
      ✓ 
      Drug product



See also...

  • Atrovent HFA Aerosol Suspension Consumer Information (Wolters Kluwer)
  • Atrovent HFA Consumer Information (Cerner Multum)
  • Ipratropium Aerosol Suspension Consumer Information (Wolters Kluwer)
  • Ipratropium Solution Consumer Information (Wolters Kluwer)
  • Ipratropium inhalation Consumer Information (Cerner Multum)
  • Alti-Ipratropium Advanced Consumer Information (Micromedex)
  • Alti-Ipratropium With Preservative Advanced Consumer Information (Micromedex)
  • Apo-Ipravent Advanced Consumer Information (Micromedex)
  • Ipratropium Bromide Nebuamp Advanced Consumer Information (Micromedex)
  • Ipratrovent Sterules Advanced Consumer Information (Micromedex)
  • Ratio-Ipratropium Advanced Consumer Information (Micromedex)
  • Ratio-Ipratropium Udv Advanced Consumer Information (Micromedex)
  • Ipratropium Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
  • Ipratropium Bromide AHFS DI Monographs (ASHP)

Monday, 24 October 2011

Mircette




In the US, Mircette (desogestrel/ethinyl estradiol systemic) is a member of the drug class contraceptives and is used to treat Abnormal Uterine Bleeding, Birth Control, Endometriosis, Gonadotropin Inhibition and Polycystic Ovary Syndrome.

US matches:

  • Mircette

Ingredient matches for Mircette



Desogestrel

Desogestrel is reported as an ingredient of Mircette in the following countries:


  • United States

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Mircette in the following countries:


  • United States

International Drug Name Search

Mannitolo Fresenius Kabi




Mannitolo Fresenius Kabi may be available in the countries listed below.


Ingredient matches for Mannitolo Fresenius Kabi



Mannitol

Mannitol is reported as an ingredient of Mannitolo Fresenius Kabi in the following countries:


  • Italy

International Drug Name Search

Friday, 21 October 2011

Buflo




Buflo may be available in the countries listed below.


Ingredient matches for Buflo



Buflomedil

Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Buflo in the following countries:


  • Taiwan

International Drug Name Search

Wednesday, 19 October 2011

Cefazolin Vatchem




Cefazolin Vatchem may be available in the countries listed below.


Ingredient matches for Cefazolin Vatchem



Cefazolin

Cefazolin is reported as an ingredient of Cefazolin Vatchem in the following countries:


  • Georgia

International Drug Name Search

Monday, 17 October 2011

Zitep




Zitep may be available in the countries listed below.


Ingredient matches for Zitep



Sulfadiazine

Sulfadiazine is reported as an ingredient of Zitep in the following countries:


  • Mexico

International Drug Name Search

Saturday, 15 October 2011

Lecetrin




Lecetrin may be available in the countries listed below.


Ingredient matches for Lecetrin



Levocetirizine

Levocetirizine dihydrochloride (a derivative of Levocetirizine) is reported as an ingredient of Lecetrin in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, 13 October 2011

Cefixim HG.Pharm




Cefixim HG.Pharm may be available in the countries listed below.


Ingredient matches for Cefixim HG.Pharm



Cefixime

Cefixime is reported as an ingredient of Cefixim HG.Pharm in the following countries:


  • Vietnam

International Drug Name Search

Cloxine




Cloxine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cloxine



Cloxacillin

Cloxacillin benzathine (a derivative of Cloxacillin) is reported as an ingredient of Cloxine in the following countries:


  • France

International Drug Name Search

Tuesday, 4 October 2011

Spashi




Spashi may be available in the countries listed below.


Ingredient matches for Spashi



Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Spashi in the following countries:


  • Indonesia

International Drug Name Search

Saturday, 1 October 2011

Levinox




Levinox may be available in the countries listed below.


Ingredient matches for Levinox



Letrozole

Letrozole is reported as an ingredient of Levinox in the following countries:


  • Greece

International Drug Name Search

Friday, 30 September 2011

Tetrazepam




Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

M03BX07

CAS registry number (Chemical Abstracts Service)

0010379-14-3

Chemical Formula

C16-H17-Cl-N2-O

Molecular Weight

288

Therapeutic Category

Muscle relaxant

Chemical Name

2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-

Foreign Names

  • Tetrazepamum (Latin)
  • Tetrazepam (German)
  • Tétrazépam (French)
  • Tetrazepam (Spanish)

Generic Names

  • Tetrazepam (OS: BAN)
  • Tétrazépam (OS: DCF)
  • CB 4261 (IS)
  • Tetrazepam (PH: BP 2010, Ph. Eur. 6)
  • Tétrazépam (PH: Ph. Eur. 6)
  • Tetrazepamum (PH: Ph. Eur. 6)

Brand Names

  • Epsipam
    Will, Belgium; Will, Luxembourg


  • Miolastan
    Sanofi-Aventis, Mexico


  • Miozepam
    Jelfa, Poland


  • Musapam
    Krewel, Germany


  • Musaril
    Sanofi-Aventis, Germany


  • Myolastan
    Aktuapharma, Belgium; Pharmapartner, Belgium; Sanofi Aventis, Tunisia; Sanofi-Aventis, Austria; Sanofi-Aventis, Belgium; Sanofi-Aventis, Chile; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Dominican Republic; Sanofi-Aventis, Ecuador; Sanofi-Aventis, France; Sanofi-Aventis, Guatemala; Sanofi-Aventis, Honduras; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Panama; Sanofi-Aventis, Poland; Sanofi-Aventis, Romania; Sanofi-Aventis, Serbia; Sanofi-Aventis, Slovakia; Sanofi-Aventis, El Salvador; Sanofi-Aventis S.A., Spain; Sanofi-Synthelabo, Luxembourg; Sanofi-Synthelabo, Peru


  • Myopam
    Chephasaar, Poland


  • Myospasmal
    TAD, Germany


  • Myozepam
    Dar-Essaydali, Tunisia


  • Panos
    Daiichi Sankyo, France


  • Relaxam
    Helcor, Romania


  • Rilex
    Teva-Gry, Germany


  • Spasmorelax
    Lindopharm, Germany


  • Tetramdura
    Mylan dura, Germany


  • Tetraratio
    ratiopharm, Poland


  • Tetra-saar
    MIP, Germany


  • Tetrazepam AbZ
    AbZ, Germany


  • Tetrazepam AL
    Aliud, Germany


  • Tétrazépam Almus
    Almus, France


  • Tetrazepam Aristo
    Aristo Pharma, Germany


  • Tétrazépam Arrow
    Arrow, France


  • Tetrazepam beta
    Betapharm, Germany


  • Tetrazepam Billix
    Billix Pharma, Germany


  • Tétrazépam Biogaran
    Biogaran, France


  • Tetrazepam EG
    Eurogenerics, Belgium


  • Tétrazépam EG
    EG Labo, France


  • Tétrazépam G Gam
    Sandoz, France


  • Tetrazepam Hexal
    Hexal, Germany


  • Tétrazépam Merck
    Mylan, France


  • Tétrazépam Qualimed
    Qualimed, France


  • Tétrazépam Ratiopharm
    Ratiopharm, France


  • Tétrazépam RPG
    RPG, France


  • Tetrazepam Sandoz
    Sandoz, Germany


  • Tétrazépam Sandoz
    Sandoz, France


  • Tetrazepam Stada
    Stada, Germany


  • Tétrazépam Teva
    Teva Santé, France


  • Tétrazépam Winthrop
    Winthrop, France


  • Tétrazépam Zydus
    Zydus, France


  • Tetrazepam-1A Pharma
    1A Pharma, Germany


  • Tetrazepam-MIP
    Chephasaar, Bulgaria; MIP, Austria; MIP, Serbia


  • Tetrazepam-neuraxpharm
    Neuraxpharm, Germany


  • Tetrazepam-ratiopharm
    Ratiopharm, Germany


  • Tetrazepam-Teva
    Teva, Germany


  • TetrazePas
    Lindopharm, Germany


  • Tetrazep-CT
    CT Arzneimittel, Germany

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Taro-Warfarin




Taro-Warfarin may be available in the countries listed below.


Ingredient matches for Taro-Warfarin



Warfarin

Warfarin sodium salt (a derivative of Warfarin) is reported as an ingredient of Taro-Warfarin in the following countries:


  • Canada

International Drug Name Search

Monday, 26 September 2011

Gemtro




Gemtro may be available in the countries listed below.


Ingredient matches for Gemtro



Gemcitabine

Gemcitabine hydrochloride (a derivative of Gemcitabine) is reported as an ingredient of Gemtro in the following countries:


  • Argentina

International Drug Name Search

Tuesday, 20 September 2011

Clindamycin Phosphate and Benzoyl Peroxide




Ingredient matches for Clindamycin Phosphate and Benzoyl Peroxide



Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Clindamycin Phosphate and Benzoyl Peroxide in the following countries:


  • United States

Clindamycin

Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Clindamycin Phosphate and Benzoyl Peroxide in the following countries:


  • United States

International Drug Name Search

Saturday, 17 September 2011

Ladogal




Ladogal may be available in the countries listed below.


Ingredient matches for Ladogal



Danazol

Danazol is reported as an ingredient of Ladogal in the following countries:


  • Argentina

  • Brazil

  • Malaysia

  • Mexico

  • Philippines

  • Singapore

  • Taiwan

  • Thailand

  • Venezuela

International Drug Name Search

Wednesday, 14 September 2011

Methocel




Methocel may be available in the countries listed below.


Ingredient matches for Methocel



Hypromellose

Hypromellose is reported as an ingredient of Methocel in the following countries:


  • Germany

  • Singapore

  • Switzerland

  • Taiwan

International Drug Name Search

Tuesday, 13 September 2011

PIP Acid




PIP Acid may be available in the countries listed below.


Ingredient matches for PIP Acid



Omeprazole

Omeprazole is reported as an ingredient of PIP Acid in the following countries:


  • Greece

International Drug Name Search

Saturday, 10 September 2011

Parlatos




Parlatos may be available in the countries listed below.


Ingredient matches for Parlatos



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Parlatos in the following countries:


  • Spain

International Drug Name Search

Thursday, 8 September 2011

Valztrex




Valztrex may be available in the countries listed below.


Ingredient matches for Valztrex



Valacyclovir

Valaciclovir hydrochloride (a derivative of Valaciclovir) is reported as an ingredient of Valztrex in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 7 September 2011

Chloropotassuril




Chloropotassuril may be available in the countries listed below.


Ingredient matches for Chloropotassuril



Potassium Chloride

Potassium Chloride is reported as an ingredient of Chloropotassuril in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Sunday, 4 September 2011

Ferodan




Ferodan may be available in the countries listed below.


Ingredient matches for Ferodan



Ferrous Sulfate

Ferrous Sulfate is reported as an ingredient of Ferodan in the following countries:


  • Canada

  • New Zealand

International Drug Name Search

Friday, 26 August 2011

Apraz




Apraz may be available in the countries listed below.


Ingredient matches for Apraz



Alprazolam

Alprazolam is reported as an ingredient of Apraz in the following countries:


  • Brazil

International Drug Name Search

Nystin




Nystin may be available in the countries listed below.


Ingredient matches for Nystin



Nystatin

Nystatin is reported as an ingredient of Nystin in the following countries:


  • Indonesia

International Drug Name Search

Tuesday, 23 August 2011

Cefax




Cefax may be available in the countries listed below.


Ingredient matches for Cefax



Cefalexin

Cefalexin is reported as an ingredient of Cefax in the following countries:


  • Sri Lanka

Ceftriaxone

Ceftriaxone is reported as an ingredient of Cefax in the following countries:


  • Ethiopia

International Drug Name Search

Sunday, 21 August 2011

Calcium para-aminosalicylate




Calcium para-aminosalicylate may be available in the countries listed below.


Ingredient matches for Calcium para-aminosalicylate



Aminosalicylic Acid

Calcium para-aminosalicylate (JAN) is known as Aminosalicylic Acid in the US.

International Drug Name Search

Glossary

JANJapanese Accepted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 16 August 2011

Lenirit




Lenirit may be available in the countries listed below.


Ingredient matches for Lenirit



Hydrocortisone

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Lenirit in the following countries:


  • Italy

International Drug Name Search

Friday, 12 August 2011

Lévodropropizine




Lévodropropizine may be available in the countries listed below.


Ingredient matches for Lévodropropizine



Levodropropizine

Lévodropropizine (DCF) is also known as Levodropropizine (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 11 August 2011

Sensivit




Sensivit may be available in the countries listed below.


Ingredient matches for Sensivit



Retinol

Retinol is reported as an ingredient of Sensivit in the following countries:


  • Serbia

International Drug Name Search

Tuesday, 2 August 2011

Big Red Flea Spray




Big Red Flea Spray may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Big Red Flea Spray



Propoxur

Propoxur is reported as an ingredient of Big Red Flea Spray in the following countries:


  • United Kingdom

International Drug Name Search

Thursday, 28 July 2011

Glitter-M




Glitter-M may be available in the countries listed below.


Ingredient matches for Glitter-M



Metformin

Metformin is reported as an ingredient of Glitter-M in the following countries:


  • India

Pioglitazone

Pioglitazone is reported as an ingredient of Glitter-M in the following countries:


  • India

International Drug Name Search

Wednesday, 27 July 2011

Butrans transdermal



Generic Name: buprenorphine (transdermal) (BUE pre NOR feen)

Brand Names: Butrans


What is this drug?

Buprenorphine is a narcotic (opioid) pain medicine.


Buprenorphine transdermal (skin patch) is used to treat moderate to severe chronic pain when treatment is needed around the clock.


Buprenorphine is not for treating pain just after surgery, or for treating occasional short-term pain.

Buprenorphine transdermal may also be used for purposes not listed in this medication guide.


What is the most important information I should know about this drug?


You should not use buprenorphine if you are allergic to it, or if you have a severe breathing disorder such as asthma, or a bowel obstruction called paralytic ileus.

Never wear more than 1 buprenorphine skin patch at a time unless your doctor has told you to.


Do not expose the skin patch to heat while you are wearing it. Heat can increase the amount of drug you absorb through your skin and may cause harmful effects.

Call your doctor at once if you have weak or shallow breathing, snoring that is new or unusual, slow heart rate, confusion, severe dizziness, seizure, or feeling like you might pass out.


Avoid letting another person handle your buprenorphine skin patches. Keep both used and unused patches out of the reach of children or pets. The amount of buprenorphine in a used skin patch could be fatal to a child or pet who accidentally sucks or chews on it. Seek emergency medical attention if this happens. Do not stop using buprenorphine suddenly, or you could have unpleasant withdrawal symptoms. Ask your doctor how to avoid withdrawal symptoms when you stop using buprenorphine.

What should I discuss with my health care provider before using this drug?


You should not use buprenorphine if you are allergic to it, or if you have:

  • asthma or severe breathing disorder; or




  • a bowel obstruction called paralytic ileus.




Do not use buprenorphine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. Serious, life threatening side effects can occur if you use buprenorphine before the MAO inhibitor has cleared from your body.

To make sure you can safely use buprenorphine, tell your doctor if you have any of these other conditions:



  • COPD (chronic obstructive pulmonary disease), sleep apnea, or other breathing disorders;




  • a personal or family history of "Long QT syndrome":




  • hepatitis B or C;




  • liver or kidney disease;




  • a thyroid disorder;




  • gallbladder disease;




  • curvature of the spine;




  • a history of head injury or brain tumor;




  • epilepsy or other seizure disorder;




  • low blood pressure;




  • Addison's disease or other adrenal gland disorders;




  • enlarged prostate, urination problems;




  • depression or other mental illness; or




  • a history of drug or alcohol addiction.




Buprenorphine may be habit-forming and should be used only by the person it was prescribed for. Never share buprenorphine with another person, especially someone with a history of drug abuse or addiction. Keep the medication in a place where others cannot get to it. FDA pregnancy category C. It is not known whether buprenorphine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. Buprenorphine can pass into breast milk and may harm a nursing baby. You should not breast-feed while you are using buprenorphine.

Your dose needs may be different if you have recently used an opioid pain medicine and your body is tolerant to it. Opioids include Tylenol #3, Lortab, Vicodin, OxyContin, Percocet, Darvocet, Actiq, morphine, and many others. Talk with your doctor if you are not sure you are opioid-tolerant.


How should I use this drug?


Use exactly as prescribed. Never use buprenorphine in larger amounts, or for longer than recommended by your doctor. Follow the directions on your prescription label. Tell your doctor if the medicine seems to stop working as well in relieving your pain.


This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


If you are switching to buprenorphine transdermal from another narcotic pain medicine, you may need to slowly stop using the other medicine. Follow your doctor's instructions.


Apply the skin patch only to clean, dry skin. Use only clear water to wash the skin before you apply a skin patch. Soaps or other chemicals could increase the amount of buprenorphine your skin absorbs.


Apply the patch to a flat and hairless area of the chest, back, side, or outer side of your upper arm. Wear the patch around the clock for 7 days. Never wear more than 1 buprenorphine skin patch at a time unless your doctor has told you to.


Do not use soaps or other chemicals could increase the amount of buprenorphine your skin absorbs.

Do not use a buprenorphine transdermal skin patch if it has been cut or damaged.


After removing a skin patch fold it in half, sticky side in, and flush the patch down the toilet or use the Patch-Disposal Unit provided with this medication. Apply a new patch to a different skin area on the chest, back, side, or upper arm. Do not use the same skin area twice in a row.


Never share this medication with another person, even if they have the same symptoms you have. Ask your doctor how to avoid withdrawal symptoms when you stop using buprenorphine. Keep both used and unused buprenorphine skin patches out of the reach of children or pets. The amount of buprenorphine in a used skin patch could be fatal to a child or pet who accidentally sucks or chews on the patch. Seek emergency medical attention if this happens.

Keep track of how many skin patches have been used from each new package of this medicine. Buprenorphine is a drug of abuse and you should be aware if any person in the household is using this medicine improperly or without a prescription.


Store at room temperature. Keep each patch in its foil pouch until you are ready to use it.

What happens if I miss a dose?


If you forget to change a patch on your scheduled day, remove the patch and apply a new one as soon as you remember. Do not wear extra patches to make up a missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. The amount of buprenorphine in a used or unused skin patch can be fatal to a child who accidentally sucks or chews on the patch.

Overdose symptoms may include extreme drowsiness, weak or limp feeling, weak pulse, cold and clammy skin, fainting, shallow breathing, snoring, or breathing that stops.


What should I avoid while using this drug?


Do not drink alcohol or you may have serious, life-threatening side effects. Buprenorphine may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Avoid getting up too fast from a sitting or lying position, or you may feel dizzy. Get up slowly and steady yourself to prevent a fall. Do not expose the skin patch to heat while you are wearing it. This includes a hot tub, heating pad, electric blanket, sauna, heated water bed, or a hot bath. Avoid exposure to sunlight or tanning beds. Heat can increase the amount of drug you absorb through your skin and may cause harmful effects. Avoid letting another person handle your buprenorphine skin patches. If the sticky side of a skin patch comes into contact with another person, wash the skin with clear water and seek medical care at once.

This drug side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using buprenorphine and call your doctor at once if you have a serious side effect such as:

  • slow heart rate, weak or shallow breathing, deep sighs, snoring that is new or unusual;




  • confusion, severe dizziness, feeling like you might pass out;




  • blisters, swelling, or severe irritation where the patch was worn;




  • seizure (convulsions); or




  • nausea, upper stomach pain, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).



Less serious side effects may include:



  • headache;




  • vomiting, dry mouth, upset stomach, constipation;




  • mild dizziness or drowsiness; or




  • redness, itching, or mild skin rash where the patch was worn.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect this drug?


Tell your doctor if you regularly use other medicines that can make you sleepy or slow your breathing (such as cold or allergy medicine, sedatives, anti-nausea medicine, other narcotic pain medicines, sleeping pills, muscle relaxers, heart rhythm medications, and medicine for seizures, depression, or anxiety). They can add to the side effects of buprenorphine and dangerous side effects may result.

  • dexamethasone (Decadron, Hexadrol);




  • St. John's wort;




  • rifabutin (Mycobutin), rifampin (Rifadin, Rifater, Rifamate), or rifapentine (Priftin);




  • phenobarbital (Solfoton) or other barbiturates;




  • diazepam (Valium) or similar medicines such as alprazolam (Xanax), lorazepam (Ativan), clorazepate (Tranxene), and others;




  • a heart rhythm medication such as amiodarone (Cordarone, Pacerone), disopyramide (Norpace), dofetilide (Tikosyn), flecaininde (Tambocor), procainamide (Pronestyl), propafenone, (Rythmol), quinidine (Quin-G), sotalol (Betapace), and others;




  • HIV medication such as efavirenz (Sustiva), etravirine (Intelence), nevirapine (Viramune), or ritonavir (Kaletra, Norvir); or




  • seizure medication such as carbamazepine (Carbatrol, Tegretol), felbamate (Felbatol), oxcarbazepine (Trileptal), phenytoin (Dilantin), or primidone (Mysoline).



This list is not complete and other drugs may interact with buprenorphine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Butrans resources


  • Butrans Side Effects (in more detail)
  • Butrans Use in Pregnancy & Breastfeeding
  • Butrans Drug Interactions
  • Butrans Support Group
  • 29 Reviews for Butrans - Add your own review/rating


Compare Butrans with other medications


  • Pain


Where can I get more information?


  • Your pharmacist can provide more information about buprenorphine.

See also: Butrans side effects (in more detail)


Tuesday, 26 July 2011

Rilace plus




Rilace plus may be available in the countries listed below.


Ingredient matches for Rilace plus



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Rilace plus in the following countries:


  • Turkey

Lisinopril

Lisinopril is reported as an ingredient of Rilace plus in the following countries:


  • Turkey

International Drug Name Search

Ciza-MPS




Ciza-MPS may be available in the countries listed below.


Ingredient matches for Ciza-MPS



Cisapride

Cisapride monohydrate (a derivative of Cisapride) is reported as an ingredient of Ciza-MPS in the following countries:


  • India

Dimeticone

Dimeticone is reported as an ingredient of Ciza-MPS in the following countries:


  • India

International Drug Name Search

Sunday, 24 July 2011

Lamotrigine Generics




Lamotrigine Generics may be available in the countries listed below.


Ingredient matches for Lamotrigine Generics



Lamotrigine

Lamotrigine is reported as an ingredient of Lamotrigine Generics in the following countries:


  • Greece

International Drug Name Search

Saturday, 23 July 2011

Detrunorm




Detrunorm may be available in the countries listed below.


UK matches:

  • Detrunorm 15 mg Tablets (SPC)
  • Detrunorm XL 30 mg Modified Release Capsules (SPC)

Ingredient matches for Detrunorm



Propiverine

Propiverine hydrochloride (a derivative of Propiverine) is reported as an ingredient of Detrunorm in the following countries:


  • Croatia (Hrvatska)

  • Ireland

  • Luxembourg

  • Slovenia

  • South Africa

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ribasphere


Generic Name: ribavirin (oral) (rye ba VYE rin)

Brand Names: Copegus, Rebetol, RibaPak, Ribasphere, RibaTab


What is ribavirin?

Ribavirin is an antiviral medication.


Ribavirin must be used together with an interferon alfa product (such as Pegasys, PegIntron, Sylatron, or Intron A) to treat chronic hepatitis C.


Ribavirin may also be used for purposes not listed in this medication guide.


What is the most important information I should know about ribavirin?


Ribavirin is not effective when used alone to treat hepatitis C. It must be used together with an interferon alfa product (such as Pegasys, PegIntron, Sylatron, or Intron A) to treat chronic hepatitis C. You should not take ribavirin if you are allergic to it, or if you have severe liver disease, autoimmune hepatitis, a hemoglobin disorder (anemia, thalassemia, and others), if you are also taking didanosine (Videx), or if you are pregnant woman, or a man whose female sexual partner is pregnant. This medication can cause birth defects or death in an unborn baby. If you are a woman, do not take ribavirin if you are pregnant. If you are a man, do not take ribavirin if your female sexual partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin.

Use at least two effective forms of birth control while either sexual partner is taking ribavirin, and for at least 6 months after treatment ends. Tell your doctor right away if a pregnancy occurs while either the mother or the father is taking ribavirin.


Ribavirin may decrease the number of red blood cells in your body. This is called anemia and it can be life-threatening in people who have heart disease or circulation problems. Your blood will need to be tested often. Your vision, liver function, and thyroid function may also need to be tested. Visit your doctor regularly. Call your doctor at once if you have pale or yellowed skin, dark colored urine, fever, confusion, chest pain, weakness, or trouble breathing.

What should I discuss with my healthcare provider before taking ribavirin?


You should not take ribavirin if you are allergic to it, or if you have:

  • severe liver disease (especially cirrhosis);




  • autoimmune hepatitis;




  • a hemoglobin disorder such as anemia, thalassemia (Mediterranean anemia), or sickle-cell anemia;




  • if you are also taking didanosine (Videx); or




  • if you are pregnant woman, or a man whose female sexual partner is pregnant.



To make sure you can safely take ribavirin, tell your doctor if you have any of these other conditions:


  • kidney or liver disease (other than hepatitis C);


  • hepatitis B infection;




  • a blood cell disorder such as hemolytic anemia (a lack of red blood cells);




  • human immunodeficiency virus (HIV or AIDS);




  • diabetes;




  • a pancreas disorder;




  • sarcoidosis;




  • breathing problems;




  • a thyroid disorder;




  • new or worsening eye problems (such as retinopathy);




  • a history of heart disease, high blood pressure, or a heart attack;




  • a history of depression or suicide attempt;




  • a history of a liver, kidney, or other organ transplant; or




  • if you have ever received treatment for hepatitis C that did not work well.




This medication can cause birth defects or death in an unborn baby.

  • If you are a woman, do not take ribavirin if you are pregnant. You will need frequent pregnancy tests to make sure you are not pregnant while taking ribavirin.




  • If you are a man, do not take ribavirin if your female sexual partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin. Your sexual partner will need frequent pregnancy tests to make sure she is not pregnant while you are taking ribavirin.




  • Use at least two effective forms of birth control while either sexual partner is taking ribavirin, and for at least 6 months after treatment ends.




  • Tell your doctor right away if a pregnancy occurs while either the mother or the father is taking ribavirin.



Your name may need to be listed on a ribavirin pregnancy registry if you become pregnant while you or your male sexual partner are taking this medication or during the 6 months after treatment ends. This is to track the outcome of the pregnancy and to evaluate any effects of ribavirin on the baby.


It is not known whether ribavirin passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are taking ribavirin. Ribavirin may affect growth in children.

How should I take ribavirin?


Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.


Ribavirin is not effective when used alone to treat hepatitis C. It must be used together with an interferon alfa product (such as Peg-Intron or Intron A) to treat chronic hepatitis C. Take this medicine with food.

Measure the liquid form of ribavirin with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


Ribavirin may decrease the number of red blood cells in your body. This is called anemia and it can be life-threatening in people who have heart disease or circulation problems. Your blood will need to be tested often. Your vision, liver function, and thyroid function may also need to be tested. Visit your doctor regularly. Call your doctor at once if you have pale or yellowed skin, dark colored urine, fever, confusion, chest pain, shortness of breath, or weakness. These may be signs of serious anemia.

Use ribavirin regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.


Drink extra fluids while you are taking ribavirin to keep from getting dehydrated, especially during exercise or in hot weather.


Ribavirin can cause dry mouth, which could lead to tooth decay or gum disease. If you vomit while taking ribavirin, rinse your mouth out with water to prevent damage to your teeth or gums. Be sure to have regular dental exams while you are taking this medication.


Store ribavirin tablets and capsules at room temperature away from moisture, heat, and light. Store ribavirin liquid (oral solution) in the refrigerator. Do not allow it to freeze.

What happens if I miss a dose?


Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. If you have not taken the medication for longer than 24 hours, call your doctor for instructions. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. Overdose symptoms may include easy bruising or bleeding, urinating less than usual or not at all, chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, or a general ill feeling.

What should I avoid while taking ribavirin?


Treatment with ribavirin does not prevent spread of the hepatitis C virus to other people. Follow your doctor's instructions about how to prevent passing the disease to another person.


Avoid drinking alcohol. It may increase your risk of liver damage. Ribavirin may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.

Ribavirin side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using ribavirin and call your doctor at once if you have a serious side effect such as:

  • problems with your vision;




  • fever, chills, body aches, flu symptoms;




  • severe pain in your upper stomach spreading to your back, nausea and vomiting, fast heart rate;




  • stabbing chest pain, wheezing, feeling short of breath;




  • severe depression, hallucinations, thoughts of suicide or hurting yourself;




  • chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling; or




  • pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness.



Less serious side effects may include:



  • headache;




  • muscle pain;




  • dry mouth;




  • nausea; vomiting, stomach pain, loss of appetite;




  • weight loss;




  • feeling tired or irritable;




  • anxiety, mood changes; or




  • pain, swelling, or irritation where the interferon injection was given.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect ribavirin?


Tell your doctor about all other medicines you use, especially:



  • abacavir (Ziagen);




  • azathiopriine (Azasan, Imuran);




  • lamivudine (Combivir, Epivir, Epzicom, Trizivir);




  • stavudine (Zerit);




  • tenofovir (Viread);




  • zalcitabine (Hivid); or




  • zidovudine (Retrovir, AZT).



This list is not complete and other drugs may interact with ribavirin. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Ribasphere resources


  • Ribasphere Side Effects (in more detail)
  • Ribasphere Use in Pregnancy & Breastfeeding
  • Drug Images
  • Ribasphere Drug Interactions
  • Ribasphere Support Group
  • 0 Reviews for Ribasphere - Add your own review/rating


  • Ribasphere Prescribing Information (FDA)

  • Ribasphere MedFacts Consumer Leaflet (Wolters Kluwer)

  • Ribasphere Advanced Consumer (Micromedex) - Includes Dosage Information

  • Ribasphere Consumer Overview

  • Ribavirin Professional Patient Advice (Wolters Kluwer)

  • Ribavirin Monograph (AHFS DI)

  • Ribavirin Prescribing Information (FDA)

  • Copegus Prescribing Information (FDA)

  • Rebetol Prescribing Information (FDA)

  • Rebetol MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rebetol Consumer Overview

  • Virazole Prescribing Information (FDA)

  • Virazole Advanced Consumer (Micromedex) - Includes Dosage Information

  • Virazole Solution MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Ribasphere with other medications


  • Hepatitis C


Where can I get more information?


  • Your pharmacist can provide more information about ribavirin.

See also: Ribasphere side effects (in more detail)


Friday, 22 July 2011

Remoxicam




Remoxicam may be available in the countries listed below.


Ingredient matches for Remoxicam



Piroxicam

Piroxicam is reported as an ingredient of Remoxicam in the following countries:


  • Serbia

International Drug Name Search

Pulvex Spot




Pulvex Spot may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Pulvex Spot



Permethrin

Permethrin is reported as an ingredient of Pulvex Spot in the following countries:


  • Belgium

International Drug Name Search

Tuesday, 19 July 2011

Lansoprazol Apotex




Lansoprazol Apotex may be available in the countries listed below.


Ingredient matches for Lansoprazol Apotex



Lansoprazole

Lansoprazole is reported as an ingredient of Lansoprazol Apotex in the following countries:


  • Belgium

International Drug Name Search

Redulip




Redulip may be available in the countries listed below.


Ingredient matches for Redulip



Simvastatin

Simvastatin is reported as an ingredient of Redulip in the following countries:


  • Tunisia

International Drug Name Search

Monday, 18 July 2011

Azithral




Azithral may be available in the countries listed below.


Ingredient matches for Azithral



Azithromycin

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Azithral in the following countries:


  • India

  • Myanmar

  • Sri Lanka

  • Vietnam

International Drug Name Search

Sunday, 17 July 2011

Clostridial Infection Medications


Drugs associated with Clostridial Infection

The following drugs and medications are in some way related to, or used in the treatment of Clostridial Infection. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Clostridial Infection

  • Tetanus (12 drugs)





Drug List:

Thursday, 14 July 2011

Aeroflux




Aeroflux may be available in the countries listed below.


Ingredient matches for Aeroflux



Ambroxol

Ambroxol is reported as an ingredient of Aeroflux in the following countries:


  • Peru

Salbutamol

Salbutamol is reported as an ingredient of Aeroflux in the following countries:


  • Peru

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Aeroflux in the following countries:


  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

  • Panama

International Drug Name Search

Wednesday, 13 July 2011

Quinine Ethylcarbonate




Quinine Ethylcarbonate may be available in the countries listed below.


Ingredient matches for Quinine Ethylcarbonate



Quinine

Quinine Ethylcarbonate (JAN) is known as Quinine in the US.

International Drug Name Search

Glossary

JANJapanese Accepted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 8 July 2011

Rino Calyptol




Rino Calyptol may be available in the countries listed below.


Ingredient matches for Rino Calyptol



Oxymetazoline

Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Rino Calyptol in the following countries:


  • Italy

International Drug Name Search

Thursday, 7 July 2011

Hydergine




In the US, Hydergine (ergoloid mesylates systemic) is a member of the drug class miscellaneous central nervous system agents and is used to treat Alzheimer's Disease, Arteriosclerotic Dementia and Dementia.

US matches:

  • Hydergine

Ingredient matches for Hydergine



Dihydroergocristine

Dihydroergocristine mesilate (a derivative of Dihydroergocristine) is reported as an ingredient of Hydergine in the following countries:


  • Hong Kong

Dihydroergotoxine

Dihydroergotoxine is reported as an ingredient of Hydergine in the following countries:


  • United States

Dihydroergotoxine mesilate (a derivative of Dihydroergotoxine) is reported as an ingredient of Hydergine in the following countries:


  • Belgium

  • Brazil

  • Canada

  • France

  • Ghana

  • Greece

  • Israel

  • Japan

  • Kenya

  • Libya

  • Malaysia

  • Nigeria

  • Oman

  • Philippines

  • Portugal

  • Sudan

  • Tanzania

  • Thailand

  • Zambia

  • Zimbabwe

International Drug Name Search

Wednesday, 6 July 2011

Elcofar




Elcofar may be available in the countries listed below.


Ingredient matches for Elcofar



Omeprazole

Omeprazole is reported as an ingredient of Elcofar in the following countries:


  • Greece

International Drug Name Search

Tuesday, 28 June 2011

Ampina




Ampina may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ampina



Ampicillin

Ampicillin sodium salt (a derivative of Ampicillin) is reported as an ingredient of Ampina in the following countries:


  • France

International Drug Name Search

Sunday, 26 June 2011

Acid-ness MK




Acid-ness MK may be available in the countries listed below.


Ingredient matches for Acid-ness MK



Aluminium Acetate

Aluminium Acetate is reported as an ingredient of Acid-ness MK in the following countries:


  • Colombia

International Drug Name Search

Saturday, 25 June 2011

Tendura




Tendura may be available in the countries listed below.


Ingredient matches for Tendura



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Tendura in the following countries:


  • Turkey

International Drug Name Search

Monday, 20 June 2011

Letonal




Letonal may be available in the countries listed below.


Ingredient matches for Letonal



Spironolactone

Spironolactone is reported as an ingredient of Letonal in the following countries:


  • Indonesia

International Drug Name Search

Saturday, 18 June 2011

Respidon




Respidon may be available in the countries listed below.


Ingredient matches for Respidon



Risperidone

Risperidone is reported as an ingredient of Respidon in the following countries:


  • Brazil

International Drug Name Search

Wednesday, 15 June 2011

Optipred




Optipred may be available in the countries listed below.


Ingredient matches for Optipred



Prednisolone

Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Optipred in the following countries:


  • Oman

International Drug Name Search

Thursday, 9 June 2011

Benlysta


Pronunciation: be-LIM-ue-mab
Generic Name: Belimumab
Brand Name: Benlysta


Benlysta is used for:

Treating certain patients with systemic lupus erythematosus (SLE). It may also be used for other conditions as determined by your doctor.


Benlysta is a B-lymphocyte stimulator (BLyS)-specific inhibitor. Patients with lupus often have high levels of a certain protein in their blood. Benlysta works by limiting the activity of that protein.


Do NOT use Benlysta if:


  • you are allergic to any ingredient in Benlysta

  • you have severe, active central nervous system lupus

  • you have certain severe kidney problems associated with lupus (severe, active lupus nephritis)

  • you are using another biologic medicine (eg, etanercept, infliximab, immune globulin)

  • you are receiving cyclophosphamide as an injection into your vein (intravenous [IV])

Contact your doctor or health care provider right away if any of these apply to you.



Before using Benlysta:


Some medical conditions may interact with Benlysta. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of a long-term infection, an infection that keeps coming back, tuberculosis (TB) infection or a positive TB skin test, or hepatitis B infection

  • if you have an infection, open cuts or sores on your body, flu-like symptoms or other signs of infection (eg, fever; chills; cough; warm, red, or painful skin), or are using medicine to treat an infection

  • if you have a history of cancer or heart problems

  • if you have a history of mental or mood problems (eg, depression), or suicidal thoughts or actions

  • if you have recently received a vaccine or are scheduled to receive a vaccine

Some MEDICINES MAY INTERACT with Benlysta. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Other biologic medicines (eg, etanercept, infliximab, immune globulin), IV cyclophosphamide, or monoclonal antibodies (eg, certolizumab, denosumab) because the risk of their side effects may be increased by Benlysta

This may not be a complete list of all interactions that may occur. Ask your health care provider if Benlysta may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Benlysta:


Use Benlysta as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Benlysta comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Benlysta refilled.

  • Benlysta is usually given as an injection into the vein at your doctor's office, hospital, or clinic.

  • You may receive another medicine before each treatment with Benlysta to decrease the chance of an allergic reaction. Discuss any questions with your doctor.

  • Do not use Benlysta if it contains particles, is cloudy or discolored, or if the syringe or pen is cracked or damaged.

  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.

  • If you miss a dose of Benlysta, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Benlysta.



Important safety information:


  • Do NOT use more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • Benlysta may lower the ability of your body to fight infection and may increase the risk of severe or fatal infection. Avoid contact with people who have colds, flu, shingles, or other infections. Tell your doctor right away if you notice signs of infection like fever, sore throat, rash, or chills.

  • Treatment with medicines similar to Benlysta may increase in the risk of developing cancer. It is possible that treatment with Benlysta may also increase this risk. Discuss any questions or concerns with your doctor.

  • Some patients using Benlysta reported mental or mood changes (eg, anxiety, depression) and suicidal thoughts or actions. The majority of these patients had a history of depression or other serious mental or mood problems. It is unknown if Benlysta is associated with an increased risk of these events. Tell your doctor right away if you develop anxiety, depression, severe or persistent trouble sleeping, suicidal thoughts or actions, or any other mental or mood changes.

  • Tell your doctor or dentist that you take Benlysta before you receive any medical or dental care, emergency care, or surgery.

  • Do not receive a live vaccine (eg, measles, mumps) while you are using Benlysta or for 30 days before you begin using it. Talk with your doctor before you receive any vaccine.

  • Benlysta may not work as well in black patients. Contact your doctor if your symptoms do not improve or if they become worse.

  • Women who may become pregnant should use effective birth control while using Benlysta and for 4 months after the last treatment. Check with your doctor if you have questions about effective birth control.

  • Benlysta should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Benlysta while you are pregnant. It is not known if Benlysta is found in breast milk. Do not breast-feed while using Benlysta.


Possible side effects of Benlysta:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea; headache; nausea; pain in the arm or leg; sinus inflammation; stomach pain; stuffy or runny nose; trouble sleeping.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; wheezing; unusual hoarseness); fainting; mental or mood changes (eg, anxiety, depression); muscle pain or weakness; severe or persistent headache or dizziness; severe or persistent trouble sleeping; suicidal thoughts or actions; symptoms of heart problems (eg, chest pain or discomfort, shortness of breath, slow heartbeat, dizziness, cold sweats); symptoms of infection (eg, fever, chills, or persistent sore throat; persistent cough; flu-like symptoms; warm, red, or painful skin; open sore that does not heal; increased or painful urination).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Benlysta side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Benlysta:

Benlysta is usually handled and stored by a health care provider. If you are using Benlysta at home, store Benlysta as directed by your pharmacist or health care provider. Keep Benlysta out of the reach of children and away from pets.


General information:


  • If you have any questions about Benlysta, please talk with your doctor, pharmacist, or other health care provider.

  • Benlysta is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Benlysta. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Benlysta resources


  • Benlysta Side Effects (in more detail)
  • Benlysta Use in Pregnancy & Breastfeeding
  • Benlysta Drug Interactions
  • Benlysta Support Group
  • 0 Reviews for Benlysta - Add your own review/rating


  • Benlysta Prescribing Information (FDA)

  • Benlysta Advanced Consumer (Micromedex) - Includes Dosage Information

  • Benlysta Consumer Overview

  • Belimumab Professional Patient Advice (Wolters Kluwer)



Compare Benlysta with other medications


  • Systemic Lupus Erythematosus